May 16, 2017
One in every three new drugs triggers side effects discovered only after Food and Drug Administration approval, new data reveals. And that statistic begs a crucial question: How can we really ensure patients’ safety in an age of sophisticated medications and accelerated approval processes?
May 10, 2017
When should patients switch from one medicine to another for non-medical reasons? How can pharmacovigilance processes successfully monitor patients’ reactions to a medicine? And, perhaps most importantly, how do we ensure that patients are informed participants in decisions about their medication?
May 9, 2017
“Doctor, make my pain go away.” I hear this plea, in one form or another, from patients on a daily basis. Yet it presents physicians like me with a troubling conundrum.
May 1, 2017
What can the federal government do to raise clinical trials awareness? Maybe a lot, suggests one organization.
April 27, 2017
Rejection is never pleasant. But for the 34,459 patients whose health plans refuse to cover advanced treatment for high cholesterol, it could also be deadly.
April 25, 2017
Robin Rogers was 35 weeks pregnant when she began to suffer from significant vomiting and dehydration. She was admitted to the hospital near her home in Kansas. To correct her fluid and nutrition levels, Robin had two tubes placed: one, a feeding tube; the other a PICC line, often used to draw blood or deliver antibiotics.
April 20, 2017
A new bureaucratic obstacle could make it even harder for asthma patients to get the medicine they need.
April 18, 2017
Promising clinical trials data has excited patients with cystic fibrosis and their families. But will access barriers dash their hopes for more and better treatment options?
April 13, 2017
What is good value in terms of cancer treatment? The question, amid rising cancer care costs, has prompted a surge of oncology value models in recent years.
April 10, 2017
Physicians and patients are no longer asking if a biological medicine is the best choice, but – more likely – which biological medicine is the best choice. This opening thought from Alliance for Patient Access Chairman David Charles, MD, set the tone for the organization’s second annual National Policy and Advocacy Summit on Biologics and Biosimilars, held Thursday in Washington, DC.
